|  | | | | |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | HE4 ELISA Assay | Calcitonin ELISA Assay | Gd-IgA1 (Galactose-deficient IgA1) ELISA | Insulin-like Growth Factor-Binding Protein-3 (IGFBP-3) ELISA | Insulin-like Growth Factor-II (IGF-II) ELISA |
| Citations | | | | | |
| Catalog Number | 404-10US | BM7024 | 27600 | E03A | E30 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The HE4 EIA is an enzyme immunometric assay for the quantitative determination of HE4 in human serum. The assay is to be used as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer. Serial testing for patient HE4 assay values should be used in The HE4 EIA is an enzyme immunometric assay for the quantitative determination of HE4 in human serum. The assay is to be used as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer. Serial testing for patient HE4 assay values should be used in conjunction with other clinical methods used for monitoring ovarian cancer.... Read More | Enzyme-linked immunosorbent assay (ELISA) for the determination of Calcitonin in human serum. This assay is intended for in vitro diagnostic use. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More | Enzyme immunoassay (ELISA) for the determination of IGFBP-3 in human serum, plasma (heparin), or cerebrospinal fluid. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of IGF-II in human serum, plasma, urine, saliva, and cell culture supernatants. For research use only, not for use in diagnostic procedures. |
| Detection Target | Alpha2,6-Sialyltransferase (Alpha2,6-ST) | 25-hydroxyvitamin D2 and D3 (25OH-D2 and 25OH-D3) | Metanephrine / Normetanephrine | Complement System Screen | Corynebacterium diphtheriae toxin IgG |
| Sample Type | Serum, Blood Plasma, Cell Culture Supernatant | Serum | Urine | Serum | Serum, Blood Plasma |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 15 to 900 pM | 10 to 300 pg/mL | 1.56 to 100.0 ng/mL | 0.4 to 30.0 ng/mL | 0.45 to 9.00 ng/mL |
| Sensitivity | 0.20 ng/mL | 3.35 ng/mL | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | Inquire | 100% (95% confidence interval: 95.44% - 100%) |
| Assay Time | 2 hrs 30 mins (incubation) | 4 hrs 30 mins (incubation) | 2 hours (incubation) | 2 hrs 30 mins (incubation) | 3 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |